Archies Adjusts Financial Strategy Amidst Market Challenges and Profitability Shifts

Nov 18 2025 03:01 PM IST
share
Share Via
Archies, a microcap in the diversified consumer products sector, has shown a more stable financial performance in its latest quarter. Despite reporting a profit after tax of Rs 0.05 crore, operational efficiency remains a concern with a negative profit before tax. The company faces significant market challenges, reflected in its stock performance.
Archies Adjusts Financial Strategy Amidst Market Challenges and Profitability Shifts
Archies, a microcap player in the diversified consumer products sector, has recently undergone a financial trend adjustment, reflecting a more stable performance in its latest quarter ending September 2025. The company's financial score has shown a notable shift, indicating a more balanced outlook compared to previous assessments.
In terms of financial metrics, Archies reported a profit after tax (PAT) of Rs 0.05 crore over the last six months, signaling a positive development in profitability. However, the profit before tax (PBT) for the latest quarter was recorded at Rs -0.21 crore, suggesting challenges in operational efficiency. When examining the company's performance relative to the broader market, Archies has faced significant headwinds. Over the past year, the stock has declined by 20.52%, while the Sensex has gained 9.64%. This trend is further highlighted by a year-to-date drop of 19.59% for Archies, contrasting sharply with the Sensex's 8.52% increase. Despite these challenges, the company has shown resilience, with a five-year return of 64.37%, although it still lags behind the Sensex's impressive 91.93% return over the same period. Overall, Archies is navigating a complex landscape, with recent adjustments reflecting both its operational challenges and its historical performance trajectory.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Archies Ltd falling/rising?
Jan 28 2026 12:48 AM IST
share
Share Via
Archies Ltd is Rated Strong Sell
Jan 26 2026 10:10 AM IST
share
Share Via
Archies Ltd is Rated Strong Sell
Jan 14 2026 10:10 AM IST
share
Share Via
Archies Ltd is Rated Strong Sell
Jan 03 2026 10:10 AM IST
share
Share Via
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
30 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
30 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
30 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
30 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
30 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
30 minutes ago
share
Share Via